63 related articles for article (PubMed ID: 10206286)
1. Soluble ICAM-1 in breast cancer: clinical significance and biological implications.
Köstler WJ; Tomek S; Brodowicz T; Budinsky AC; Flamm M; Hejna M; Krainer M; Wiltschke C; Zielinski CC
Cancer Immunol Immunother; 2001 Nov; 50(9):483-90. PubMed ID: 11761443
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma.
Ramoner R; Rahm A; Gander H; Stollenwerk B; Falkensammer C; Leonhartsberger N; Thurnher M
Cancer Immunol Immunother; 2008 Aug; 57(8):1207-14. PubMed ID: 18322685
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Wang Y; Li G; Wan F; Dai B; Ye D
Oncol Lett; 2018 Jul; 16(1):866-874. PubMed ID: 29963157
[TBL] [Abstract][Full Text] [Related]
4. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.
Shrotriya S; Walsh D; Bennani-Baiti N; Thomas S; Lorton C
PLoS One; 2015; 10(12):e0143080. PubMed ID: 26717416
[TBL] [Abstract][Full Text] [Related]
5. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.
Cross BW; Johnson TV; Derosa AB; Ogan K; Pattaras JG; Nieh PT; Kucuk O; Harris WB; Master VA
Int J Surg Oncol; 2012; 2012():524981. PubMed ID: 22900160
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma.
Ramoner R; Rahm A; Falkensammer CE; Leonhartsberger N; Thurnher M
Cancer Immunol Immunother; 2010 Aug; 59(8):1141-7. PubMed ID: 20182873
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable.
Vogl UM; Zehetgruber H; Dominkus M; Hejna M; Zielinski CC; Haitel A; Schmidinger M
Br J Cancer; 2006 Sep; 95(6):691-8. PubMed ID: 16940978
[TBL] [Abstract][Full Text] [Related]
9. An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma.
Royston P; Reitz M; Atzpodien J
Br J Cancer; 2006 Jun; 94(12):1785-8. PubMed ID: 16736003
[TBL] [Abstract][Full Text] [Related]
10. Is treatment with interferon-alpha effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions.
Royston P; Sauerbrei W; Ritchie A
Br J Cancer; 2004 Feb; 90(4):794-9. PubMed ID: 14970855
[TBL] [Abstract][Full Text] [Related]
11. Metastatic renal carcinoma comprehensive prognostic system.
Atzpodien J; Royston P; Wandert T; Reitz M;
Br J Cancer; 2003 Feb; 88(3):348-53. PubMed ID: 12569375
[TBL] [Abstract][Full Text] [Related]
12. Novel concepts in the staging of renal cell carcinoma.
Leibovici D; Lindner A; Sella A; Zisman A
Curr Urol Rep; 2003 Feb; 4(1):41-8. PubMed ID: 12537938
[TBL] [Abstract][Full Text] [Related]
13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis.
Zhang GJ; Adachi I
Int J Oncol; 1999 Jan; 14(1):71-7. PubMed ID: 9863011
[TBL] [Abstract][Full Text] [Related]
15. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
[TBL] [Abstract][Full Text] [Related]
16. [Sedimentation rate and renal cancer].
Iversen OH; Røger M; Wetteland P; Solberg HE
Tidsskr Nor Laegeforen; 1997 Jun; 117(17):2493-6. PubMed ID: 9265313
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in patients with non-metastatic renal cell carcinoma].
Inomiya H; Isaka S; Okano T; Shimazaki J; Igarashi T; Matsuzaki O
Nihon Hinyokika Gakkai Zasshi; 1996 Sep; 87(9):1099-104. PubMed ID: 8914392
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma.
Hoffmann R; Franzke A; Buer J; Sel S; Oevermann K; Duensing A; Probst M; Duensing S; Kirchner H; Ganser A; Atzpodien J
Br J Cancer; 1999 Apr; 79(11-12):1742-5. PubMed ID: 10206286
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
